A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.

about

A comprehensive review of sexual health concerns after cancer treatment and the biopsychosocial treatment options available to female patients.

P2860

Q47670995-83C143EB-68D6-4461-B6D7-A47C4FD0F2EA

P2860

A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.

Item

http://www.wikidata.org/entity/Q38947105

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

A pilot randomized trial to pr ...... t aromatase inhibitor therapy.

@en

type

Item

label

A pilot randomized trial to pr ...... t aromatase inhibitor therapy.

@en

prefLabel

A pilot randomized trial to pr ...... t aromatase inhibitor therapy.

@en

P1476

A pilot randomized trial to pr ...... t aromatase inhibitor therapy.

@en

P2093

Abenaa M Brewster

http://www.w3.org/2001/XMLSchema#string

George P Baum

http://www.w3.org/2001/XMLSchema#string

Leslie R Schover

http://www.w3.org/2001/XMLSchema#string

Pragati Advani

http://www.w3.org/2001/XMLSchema#string

P2860

Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials

Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body Study

Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.

Erectile hydraulics: maximizing inflow while minimizing outflow.

Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States.

Sexual problems during the first 2 years of adjuvant treatment with aromatase inhibitors.

Improving appropriate use of antifungal medications: the role of an over-the-counter vaginal pH self-test device.

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.

Barriers to recruitment in psycho-oncology: unique challenges in conducting research focusing on sexual health in female survivorship.

Increasing women's sexual desire: The comparative effectiveness of estrogens and androgens.

P2888

s11764-017-0606-3

P304

477-485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11764-017-0606-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083859396

http://www.w3.org/2001/XMLSchema#string

P698

28229275

http://www.w3.org/2001/XMLSchema#string

A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.

about

P2860

P2860

A pilot randomized trial to prevent sexual dysfunction in postmenopausal breast cancer survivors starting adjuvant aromatase inhibitor therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698